Komori
Financial results presentation3649FINDEX Inc.Information and Communications, Services and Others

Supplementary Information on Financial Results for the First Quarter of the Fiscal Year Ending December 2026

In the first quarter of the fiscal year ending December 2026, revenue increased 2.0% year on year, while operating profit declined 2.4% due to higher personnel expenses resulting from aggressive hiring. The Medical and Healthtech businesses offset the decline in revenue in the Public business, and operating profit reached 43.9% of the full-year plan.

Worth reading
70In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
-2.4
Year-on-year change in operating profit (%)
Wording
Conditional
How definitive the wording is.

Contents of this document

Supplementary materials to the earnings reportFirst quarter of the fiscal year ending December 202614 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥1,989 million+2.0%
Operating profit¥803 million-2.4%
Ordinary income¥825 million-1.9%
Net income¥563 million-2.6%
Gross Profit Margin70.8 %
Operating profit margin40.4 %
Selling, general and administrative expenses¥605 million
Results for the three months of the current quarterRevenue: ¥1,989 million; operating profit: ¥803 million; ordinary profit: ¥825 million; net profit attributable to owners of the parent: ¥563 million
Full-year earnings forecast
Net Sales
¥6,209 million
Operating profit
¥1,829 million
Ordinary income
¥1,889 million
Profit attributable to owners of the parent
¥1,302 million
Progress against full-year forecast　通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales32
Operating profit43.9
Ordinary income43.7
Profit attributable to owners of the parent43.3
Medical business revenue33.4
Public business revenue24.6
Healthtech business revenue18.8
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
The Medical and Public businesses are both progressing steadily against plan. The Healthtech business got off to a slow start.
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Operating profit
Revenue factors26
Gross margin factors35
Selling, general and administrative expense factor-82
Operating profit by segment
Healthcare business38
Public-sector business-101
Healthtech business43
New initiatives
  • Promotion of the medical data platform business and preparations for the full-scale launch of the certified business
  • Preparations to open a new medical data business site
  • Renewal of the in-house ERP system
  • Promotion of the goggle-type medical device development project
  • Introduction of cloud services and stronger sales promotion in the Medical business
Key KPIsA metric the company considers important as a management benchmark.
  • Number of facilities using medical systems2,259 Facility
  • Number of facilities using public-sector systems78 Facility
  • Total DocuMaker Office users49,748 people
  • Share of recurring revenue in the Medical segment25.8 %
    Year on year against the same period last year+1.5%
  • Medical system penetration at the main hospitals of Japanese university hospitals80 %
  • Penetration at large hospitals in Japan40 %
Unit price and quantity metricsThese figures show sales broken down by price and volume.
Average number of packages per facility: large hospitals 4.72, medium-sized hospitals 3.09, small hospitals 2.34 (FY26 Q1)
Segment results
Healthcare business
Net Sales
¥1,822 million+4.6%
Operating profit
¥778 million+5.2%
Public-sector business
Net Sales
¥103 million-45.7%
Operating profit
¥32 million-75.9%
Healthtech business
Net Sales
¥64 million+224.5%
Operating profit
¥-7 million
Medium-term management plan targets
Revenue in FY203085
Revenue unitHundreds of millions of yen
FY2030 operating profit32
Operating profit unitHundreds of millions of yen
Revenue CAGR8.2%
Operating income CAGR15.2%
Financial targets
ROEMaintain and improve over the medium to long term at above 20%
Market Size / Share
  • Domestic market size for document management systems740 Hundreds of millions of yen
  • TAM of the Public business740 Hundreds of millions of yen
  • SAM of the Public business400 Hundreds of millions of yen
  • SOM of the Public business55 Hundreds of millions of yen
  • Global market size for visual field analyzers500 Hundreds of millions of yen
  • Domestic market size for visual field analyzers21 Hundreds of millions of yen
  • Penetration at the main hospitals of Japanese university hospitals80 %
Number of stores and locations
Number of stores: Not disclosed. Medical systems were in use at 2,259 facilities (+13 quarter on quarter), and public-sector systems were in use at 78 facilities (+10 quarter on quarter). Preparations are under way to open a new data-business site.
Number of employees
Hiring increased by 20 people year on year. Total employees: Not disclosed.
Annual Dividend
Fiscal year ending December 2026
Interim13
End of period14
Annual27
Payout ratio
Forecast for the fiscal year ending December 202650 %
DOE floor8.5％
Acquisition of treasury shares
Reference was made to share repurchases. The repurchase amount, number of shares and period: Not disclosed.
Contents of this document
ItemDetails
Document typeSupplementary materials to the earnings report
Fiscal Period CoveredFirst quarter of the fiscal year ending December 2026
Net Sales¥1,989 million (YoY +2.0%)
Operating profit¥803 million (YoY -2.4%)
Ordinary income¥825 million (YoY -1.9%)
Net income¥563 million (YoY -2.6%)
Gross Profit Margin70.8 %
Operating profit margin40.4 %
Selling, general and administrative expenses¥605 million
Results for the three months of the current quarterRevenue: ¥1,989 million; operating profit: ¥803 million; ordinary profit: ¥825 million; net profit attributable to owners of the parent: ¥563 million
Full-year earnings forecastNet Sales ¥6,209 million / Operating profit ¥1,829 million / Ordinary income ¥1,889 million / Profit attributable to owners of the parent ¥1,302 million
Progress against full-year forecastNet Sales 32 / Operating profit 43.9 / Ordinary income 43.7 / Profit attributable to owners of the parent 43.3 / Medical business revenue 33.4 / Public business revenue 24.6 / Healthtech business revenue 18.8
Self-assessment against the planThe Medical and Public businesses are both progressing steadily against plan. The Healthtech business got off to a slow start.
Segment resultsHealthcare business Net Sales ¥1,822 million (YoY +4.6%) / Operating profit ¥778 million (YoY +5.2%) / Public-sector business Net Sales ¥103 million (YoY -45.7%) / Operating profit ¥32 million (YoY -75.9%) / Healthtech business Net Sales ¥64 million (YoY +224.5%) / Operating profit ¥-7 million
Breakdown of Factors Affecting the ChangeOperating profit Revenue factors 26 / Gross margin factors 35 / Selling, general and administrative expense factor -82 / Operating profit by segment Healthcare business 38 / Public-sector business -101 / Healthtech business 43
Key KPIsIndicator name Number of facilities using medical systems / Value 2,259 Facility / Year on year against the same period last year Not disclosed, Indicator name Number of facilities using public-sector systems / Value 78 Facility / Year on year against the same period last year Not disclosed, Indicator name Total DocuMaker Office users / Value 49,748 people / Year on year against the same period last year Not disclosed, Indicator name Share of recurring revenue in the Medical segment / Value 25.8 % / Year on year against the same period last year 1.5 %, Indicator name Medical system penetration at the main hospitals of Japanese university hospitals / Value 80 % / Year on year against the same period last year Not disclosed, Indicator name Penetration at large hospitals in Japan / Value 40 % / Year on year against the same period last year Not disclosed
Unit price and quantity metricsAverage number of packages per facility: large hospitals 4.72, medium-sized hospitals 3.09, small hospitals 2.34 (FY26 Q1)
Number of stores and locationsNumber of stores: Not disclosed. Medical systems were in use at 2,259 facilities (+13 quarter on quarter), and public-sector systems were in use at 78 facilities (+10 quarter on quarter). Preparations are under way to open a new data-business site.
Number of employeesHiring increased by 20 people year on year. Total employees: Not disclosed.
Medium-term management plan targetsRevenue in FY2030 85 / Revenue unit Hundreds of millions of yen / FY2030 operating profit 32 / Operating profit unit Hundreds of millions of yen / Revenue CAGR 8.2% / Operating income CAGR 15.2%
Financial targetsROE Maintain and improve over the medium to long term at above 20% / Equity ratio Not disclosed / ROIC Not disclosed / Debt-to-equity ratio Not disclosed
Annual DividendFiscal year ending December 2026 Interim 13 / End of period 14 / Annual 27
Payout ratioForecast for the fiscal year ending December 2026 50 % / DOE floor 8.5％
Acquisition of treasury sharesReference was made to share repurchases. The repurchase amount, number of shares and period: Not disclosed.
Market Size / Share740 Hundreds of millions of yen, 740 Hundreds of millions of yen, 400 Hundreds of millions of yen, 55 Hundreds of millions of yen, 500 Hundreds of millions of yen, 21 Hundreds of millions of yen, 80 %
New initiativesPromotion of the medical data platform business and preparations for the full-scale launch of the certified business, Preparations to open a new medical data business site, Renewal of the in-house ERP system, Promotion of the goggle-type medical device development project, Introduction of cloud services and stronger sales promotion in the Medical business
Items this document does not state (5)
Assumptions Underlying the Business OutlookRisk amount incorporated into the outlookCapital expendituresOrders received and order backlogKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Medical and Healthtech businesses offset the decline in revenue in the Public business, while personnel expenses increased due to aggressive hiring, primarily for the medical data platform business, and base-pay increases, resulting in lower operating profit. The Public business also recorded lower profit due to the reaction to a large project in the same period of the previous year.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Supplementary Information on Financial Results for the First Quarter of the Fiscal Year Ending December 2026 | FINDEX Inc. (3649) timely disclosure | Komori